HONGENE BIOTECH Trademark

Trademark Overview


On Friday, May 10, 2024, a trademark application was filed for HONGENE BIOTECH with the United States Patent and Trademark Office. The USPTO has given the HONGENE BIOTECH trademark a serial number of 98544404. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, February 18, 2025. This trademark is owned by SHANGHAI HONGENE BIOTECH CORPORATION. The HONGENE BIOTECH trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

biological preparations for treatment and prevention of ocular disease, cerebral disease, central nervous system disease, cardiovascular disease and metabolic disease for medical purposes; biological preparations for treatment and prevention of ocular disease, cerebral disease, central nervous system disease, cardiovascular disease and metabolic disease for veterinary purposes; capsules sold empty for medicines; chemical preparations for medical purposes for treatment and prevention of ocular disease, cerebral disease, central nervous system disease, cardiovascular disease and metabolic disease; chemical preparations for treatment and prevention of ocular disease, cerebral disease, central nervous system disease, cardiovascular disease and metabolic disease for pharmaceutical purposes; chemical preparations for treatment and prevention of ocular disease, cerebral disease, central nervous system disease, cardiovascular disease and metabolic disease for veterinary purposes; chemical reag...

adjuvants, other than for medical or veterinary purposes; bases in the nature of alkalies being chemical preparations; biochemical catalysts; biological preparations for use in industry and science, other than for medical or veterinary purposes; carbonic hydrates; biochemical catalysts; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; diagnostic preparations for research laboratory use; diagnostic preparations, other than for medical or veterinary purposes; enzyme preparations for industrial purposes; enzymes for industrial purposes; ferments for chemical purposes, namely, fermentation extract; glucose for industrial purposes, namely, glucosides; industrial chemicals; isotopes for industri...
hongene biotech

General Information


Serial Number98544404
Word MarkHONGENE BIOTECH
Filing DateFriday, May 10, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, February 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 11, 2025

Trademark Statements


Description of MarkThe mark consists of the stylized stacked words HONGENE BIOTECH to the left of which is a triangular shape comprised of the letters HG.
Goods and Servicesbiological preparations for treatment and prevention of ocular disease, cerebral disease, central nervous system disease, cardiovascular disease and metabolic disease for medical purposes; biological preparations for treatment and prevention of ocular disease, cerebral disease, central nervous system disease, cardiovascular disease and metabolic disease for veterinary purposes; capsules sold empty for medicines; chemical preparations for medical purposes for treatment and prevention of ocular disease, cerebral disease, central nervous system disease, cardiovascular disease and metabolic disease; chemical preparations for treatment and prevention of ocular disease, cerebral disease, central nervous system disease, cardiovascular disease and metabolic disease for pharmaceutical purposes; chemical preparations for treatment and prevention of ocular disease, cerebral disease, central nervous system disease, cardiovascular disease and metabolic disease for veterinary purposes; chemical reagents for medical or veterinary purposes; chemico-pharmaceutical preparations for treatment and prevention of ocular disease, cerebral disease, central nervous system disease, cardiovascular disease and metabolic disease; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes; diagnostic preparations for medical purposes used by medical laboratories; diagnostic preparations for veterinary purposes; drugs being pharmaceutical preparations for treatment and prevention of ocular disease, cerebral disease, central nervous system disease, cardiovascular disease and metabolic disease for medical purposes; enzyme preparations for medical purposes; enzyme preparations for veterinary purposes; enzymes for medical purposes; enzymes for veterinary purposes; ferments for pharmaceutical purposes; immunostimulants; isotopes for medical purposes; medical preparations for slimming purposes; medicinal hair growth preparations; medicines for treatment and prevention of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection, obesity, hair loss for human purposes; medicines for veterinary purposes for treatment and prevention of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection, obesity, hair loss; pharmaceutical preparations for treatment and prevention cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection, obesity, hair loss; pharmaceuticals for treatment and prevention of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection, obesity, hair loss; phosphates for pharmaceutical purposes for treatment and prevention of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection, obesity, hair loss; preparations of microorganisms for medical or veterinary use; vaccines; veterinary preparations for treatment and prevention of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection, obesity, hair loss
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Servicesadjuvants, other than for medical or veterinary purposes; bases in the nature of alkalies being chemical preparations; biochemical catalysts; biological preparations for use in industry and science, other than for medical or veterinary purposes; carbonic hydrates; biochemical catalysts; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; diagnostic preparations for research laboratory use; diagnostic preparations, other than for medical or veterinary purposes; enzyme preparations for industrial purposes; enzymes for industrial purposes; ferments for chemical purposes, namely, fermentation extract; glucose for industrial purposes, namely, glucosides; industrial chemicals; isotopes for industrial purposes preparations of microorganisms, other than for medical and veterinary use; salts being chemical preparations; sulfides
NOT AVAILABLEBIOTECH

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, May 10, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 10, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSHANGHAI HONGENE BIOTECH CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressShanghai 200233
CN

Trademark Events


Event DateEvent Description
Sunday, November 10, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, May 10, 2024NEW APPLICATION ENTERED
Sunday, November 10, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 25, 2024NON-FINAL ACTION WRITTEN
Monday, November 25, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 25, 2024NON-FINAL ACTION E-MAILED
Monday, November 25, 2024ASSIGNED TO EXAMINER
Thursday, February 13, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 13, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 14, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 5, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 13, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED